Sophoraflavanone G: A review of the phytochemistry and pharmacology
Authors:
- 18 June 2024
- journal article
- review article
- Published by Elsevier in Fitoterapia
- Vol. 177, 106080
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Sophoraflavanone G suppresses the progression of triple‐negative breast cancer via the inactivation of EGFR–PI3K–AKT signalingDrug Development Research, 2022
- Multidrug efflux transporter ABCG2: expression and regulationCellular and Molecular Life Sciences, 2021
- Antiparasitic Efficacy of Crude Plant Extracts and Compounds Purified from Plants against the Fish Monogenean Neobenedenia girellaeJournal of Aquatic Animal Health, 2021
- Involvement of mTOR‐related signaling in antidepressant effects of Sophoraflavanone G on chronically stressed micePhytotherapy Research, 2020
- Biologically active prenylated flavonoids from the genus Sophora and their structure–activity relationship—A reviewPhytotherapy Research, 2019
- HPLC-based activity profiling for GABAA receptor modulators from the traditional Chinese herbal drug Kushen (Sophora flavescens root)Molecular Diversity, 2011
- Antibacterial activity of sophoraflavanone G Isolated from the roots of Sophora flavescens against methicillin‐resistant Staphylococcus aureusPhytotherapy Research, 2009
- Effects of sophoraflavanone g, a prenylated flavonoid from sophoraFlavescens, on cyclooxygenase-2 andIn Vivo inflammatory responseArchives of Pharmacal Research, 2002
- Anti-inflammatory drugs and their mechanism of actionInflammation Research, 1998
- In vitro antitumour activity of flavonoids from Sophora flavescensPhytotherapy Research, 1997